Biologics

Before We Pass Health Insurance Reform, We Must Do More to Limit Big Pharma's Monopoly on Biologics

Marcy Winograd | Posted 11.02.2009 | Politics


Marcy Winograd

In Congress, I will work to support affordable prices on biologics, so that victims of cancer, HIV, diabetes, Parkinsons, rheumatoid arthritis, and multiple sclerosis can afford the medicine they need to stay alive.

Anna Eshoo's PhRMA Boondoggle: The Devil Is In Her Details

Jane Hamsher | Posted 11.02.2009 | Politics


Jane Hamsher

Thank you, Rep. Eshoo, for your commitment to having a bill that does not allow for "evergreening." Now the question becomes -- how are we going to get one?

House Health Care Bill: A Death Sentence For My Fellow Breast Cancer Survivors

Jane Hamsher | Posted 10.29.2009 | Politics


Jane Hamsher

Pelosi made a choice about the lifesaving biologic drugs I took when I was in chemotherapy that will cost many fellow breast cancer survivors everything they own, and quite possibly their lives.

Protecting Pharmaceutical Profits: The Cost Is Human Lives

Jane Hamsher | Posted 10.27.2009 | Politics


Jane Hamsher

The public option has received the lion's share of attention in the health care debate, but there's an equally important issue relating to generic drugs that could mean lifesaving drugs remain too expensive for all but the wealthy.

A Little-Discussed Issue That Puts "Care" Back in Health Care Reform

Kate Kelly | Posted 10.20.2009 | Politics


Kate Kelly

Legislation concerning the changes for the drug approval process on a special type of medicine (biologic medicines) could provide huge savings -- a major need with health care reform.

Why We Can't Forget about HIV/AIDS in Health-Care Reform

David Mixner | Posted 11.22.2009 | Living


David Mixner

For nearly three decades, too many people have died and millions more are living with HIV/AIDS' painful realities. Stated simply, it is far from over.